We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

340B Program: PhRMA Files Court Challenge to Final Rule on Orphan Drug Exception

04 October 2013

Health, Pharmaceutical, and Biotechnology Alert

This past Friday, September 27, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed suit against the Department of Health and Human Services (HHS) challenging the 340B orphan drug final rule. The complaint seeks both to invalidate the final rule as well as to enjoin (stop) its implementation.

Read More: 340B Program: PhRMA Files Court Challenge to Final Rule on Orphan Drug Exception

The team

Loading data